ALX Oncology Holdings Inc.

8-K Director or officer change; Regulation FD disclosure; Other events Jun 30, 2026 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation Jun 26, 2026 8-K Shareholder vote results Jun 11, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 8-K Results of operations (earnings release) May 8, 2026 8-K Director or officer change; Regulation FD disclosure Apr 13, 2026 10-K Fiscal year ended 2025-12-31 Mar 9, 2026 8-K Results of operations (earnings release) Feb 27, 2026 8-K Entered a material agreement; Other events Jan 30, 2026 8-K Other events Jan 30, 2026 8-K Director or officer change Jan 21, 2026 10-Q Quarter ended 2025-09-30 Nov 7, 2025 8-K Results of operations (earnings release) Nov 7, 2025 8-K Director or officer change; Other events Sep 12, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release); Director or officer change; Other events Aug 12, 2025 8-K Shareholder vote results Jun 12, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Delisting notice or listing-rule failure Apr 25, 2025 10-K Fiscal year ended 2024-12-31 Mar 6, 2025 8-K Results of operations (earnings release) Mar 6, 2025 8-K Exit or disposal costs; Director or officer change Mar 5, 2025 8-K Director or officer change; Regulation FD disclosure; Other events Jan 22, 2025 8-K Director or officer change Jan 17, 2025 8-K Director or officer change; Regulation FD disclosure; Other events Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release); Director or officer change Nov 7, 2024 8-K Director or officer change Oct 4, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Director or officer change; Other events Aug 6, 2024 8-K Shareholder vote results Jun 17, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Director or officer change May 2, 2024 10-K Fiscal year ended 2023-12-31 Mar 7, 2024 8-K Results of operations (earnings release) Mar 7, 2024 8-K Entered a material agreement; Took on a direct financial obligation Dec 26, 2023 10-Q Quarter ended 2023-09-30 Nov 13, 2023